A vial ships from an anonymous seller with a PDF that says 99 percent pure, and the buyer reads it as a clean bill of health. That number answers a much narrower question than most people think.
Peptides Are Built One Link at a Time
A peptide is a short chain of amino acids. Synthetic ones are usually assembled residue by residue on a solid support, each amino acid coupled onto the growing chain in sequence. Every coupling step is a chance to fail. When one does, the chain keeps growing without that link, and you get a molecule that is nearly the one you wanted, minus a piece.
The FDA calls these peptide-related impurities, and describes them in its guidance on synthetic peptide drug products (final guidance, May 2021) as sequences "related to, but different from" the active ingredient, produced by insertion, deletion, or modification such as oxidation. They are not dirt in the bottle. They are near-copies of what you were trying to make, which is what makes them hard to see and worth naming.
Peptide Is a Chemistry Word and a Legal One
Under the FDA's 2020 final rule defining "biological product", a protein is an amino acid polymer with a specific, defined sequence greater than 40 amino acids. A chain of 40 or fewer is a peptide, regulated as a drug unless it independently meets the biologics definition, as a peptide vaccine would. Regulated as a drug is not the same as approved as one: none of the seven peptides now in the compounding conversation has an approved application, and eligibility turns on a separate three-part test.
The Last One Percent Is the Part That Matters
Here is one place the regulated world has put a number on it. That guidance is a nonbinding recommendation with a narrow scope: synthetic versions of five already-approved peptide drugs (glucagon, liraglutide, nesiritide, teriparatide, teduglutide). Within that scope, the FDA says applicants should generally identify each peptide-related impurity present at 0.10 percent of the drug substance or greater, and that a new impurity above 0.5 percent could raise immunogenicity concerns that may not be answerable through an abbreviated application.
So where the FDA has written the expectation down, it is not a single number. It is: characterize the fragments down to a tenth of a percent, and justify the new ones. A certificate reporting purity alone, with no sterility, endotoxin, residual solvent, or heavy metal testing behind it, is not answering that question. Our glossary has the terms.
The Danger Is the Supply, Not the Molecule
None of this says whether these peptides work. It does not say they are safe either. The point is narrower: an unverified supply chain stacks a second risk on top of whatever the molecule's own risks turn out to be, and that second one is avoidable. Two vials can carry identical labels and identical purity claims without that number telling you the contents match.
What resolves it is a chain of custody: a licensed pharmacy, a validated method, a batch record, and a name on the paperwork. That answers what is in the vial, not whether the contents help anyone, and we are not claiming otherwise. See how to tell a licensed pharmacy from a grey-market seller and our safety page.
The Honest Asterisk
In late July 2026, the FDA's Pharmacy Compounding Advisory Committee voted to support easing restrictions on six peptides for the Section 503A bulk substances list. A recommendation is not a rule and not an approval. Notice-and-comment rulemaking still has to happen before any pharmacy has clear legal authority, and each substance was evaluated for a specific proposed use. Follow it on our regulatory tracker and how the review works.
Peppies is an independent, for-profit venture and a disclosed advocate, not a neutral party: we would benefit only from a future legal, tested peptide market, and we say so at /about. We do not sell peptides, we are not affiliated with the FDA, and nothing here is medical advice. None of these substances has been evaluated or approved by the FDA for the uses discussed, and we make no claim that any peptide is safe or effective.
Get notified when the FDA takes the next step that carries legal weight.